Monoclonal anti-CD18 antibody prevents transcellular biosynthesis of cysteinyl leukotrienes in vitro and in vivo and protects against leukotriene-dependent increase in coronary vascular resistance and myocardial stiffness

Circulation. 2000 Mar 28;101(12):1436-40. doi: 10.1161/01.cir.101.12.1436.

Abstract

Background: Cysteinyl leukotrienes (cys-LT) can constrict small and large vessels and increase vascular permeability. Formation of cys-LT arising from polymorphonuclear leukocytes (PMNL) and endothelial cell cooperation (transcellular synthesis) led to the hypothesis that PMNL-endothelial cell adhesion may represent a key step toward the formation of vasoactive cys-LT.

Methods and results: We studied the effect of pretreatment with a monoclonal antibody directed against the CD18 subunit of PMNL beta(2)-integrin on the synthesis of cys-LT in a PMNL-perfused isolated rabbit heart in vitro and in a model of permanent ligature of the left descending coronary artery in the rabbit in vivo. Challenge of PMNL-perfused rabbit hearts with formyl-met-leu-phe (0.3 micromol/L) caused synthesis of cys-LT and increase in coronary perfusion pressure that were prevented by the anti-CD18 antibody. Similar results were obtained with the use of A-23187 (0.5 micromol/L) as a challenge. Persistence of PMNL-associated myeloperoxidase activity in the perfusion buffer was observed in the presence of the anti-CD18 antibody, indicating decreased PMNL infiltration. Coronary artery ligature in vivo increased urinary excretion of leukotriene E(4), supporting the activation of the 5-lipoxygenase pathway during experimental acute myocardial infarction. Pretreatment with the anti-CD18 antibody (1 mg/kg) prevented the increase in leukotriene E(4) excretion.

Conclusions: These data support the importance of adhesion in promoting cys-LT formation, originating from PMNL-endothelial cell cooperation, and contributing to myocardial stiffness and increased coronary resistance.

MeSH terms

  • Animals
  • Antibodies, Monoclonal*
  • CD18 Antigens / immunology*
  • Calcimycin / pharmacology
  • Cysteine / biosynthesis*
  • Cysteine / physiology
  • Endothelium, Vascular / physiology
  • Heart / drug effects
  • Heart / physiology*
  • In Vitro Techniques
  • Inflammation Mediators / pharmacology
  • Leukotrienes / biosynthesis*
  • Leukotrienes / physiology*
  • Leukotrienes / urine
  • Myocardial Infarction / urine
  • Neutrophils / chemistry
  • Rabbits
  • Vascular Resistance / drug effects
  • Vascular Resistance / physiology*

Substances

  • Antibodies, Monoclonal
  • CD18 Antigens
  • Inflammation Mediators
  • Leukotrienes
  • cysteinyl-leukotriene
  • Calcimycin
  • Cysteine